Lupin Gains On Receiving US FDA Nod To Launch Drug For Onychomycosis
Tuesday, July 13, 2021
Comment
Lupin received approval to launch Tavaborole Topical Solution, 5 per cent in United States (US) from the United States Food and Drug Administration (FDA).
from NDTV Profit - Latest https://ift.tt/3yRmnfP
from NDTV Profit - Latest https://ift.tt/3yRmnfP
0 Response to "Lupin Gains On Receiving US FDA Nod To Launch Drug For Onychomycosis"
Post a Comment